Adjuvant chemoradiotherapy (CRT) plus pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) with high risk of recurrence after neoadjuvant CRT plus surgery: A single-arm phase II study.

Authors

null

Jhe-Cyuan Guo

National Taiwan University Cancer Center, Taipei, Taiwan

Jhe-Cyuan Guo , Ta-Chen Huang , Hung-Yang Kuo , Chia-Chi Lin , Feng-Ming Hsu , Jason C. Cheng , Yen-Lin Huang , Min-Shu Hsieh , Pei-Ming Huang , Jang-Ming Lee , Shu-Ling Wu , Chih-Hung Hsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03322267

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 320)

DOI

10.1200/JCO.2024.42.3_suppl.320

Abstract #

320

Poster Bd #

E20

Abstract Disclosures